Insiders · Profile

Harding David

Chief Commercial Officer at Tempest Therapeutics. Filing since 10 Apr 2014. CIK 0001340147

Company

Date

Role

Action

Amount

Of holding

10 Apr 2014

Chief Commercial Officer

Bought

1,000

$32.23K

77.5%

1 decision on file.